The birds include roughly 1.4 million laying hens and 360,000 pullets, representing about 2.7% of the company's total flock, the egg producer said.
Cal-Maine to cull 1.8 million birds, halt production at Florida facility after bird flu detected
RIDGELAND, Miss., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (Nasdaq: CALM) (“Cal-Maine Foods,” “we,” “us,” “our” or the “Company”), today reported that one of its facilities in Florida tested positive for highly pathogenic avian influenza (HPAI), which will result in the ultimate depopulation of approximately 1.4 million laying hens and 360,000 pullets, or 2.7% of the Company's flock. Production at the facility has temporarily ceased as the Company follows the protocols prescribed by the U.S. Department of Agriculture (USDA).
BCGM Wealth Management LLC purchased a new position in Cal-Maine Foods, Inc. (NASDAQ: CALM) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 25,657 shares of the basic materials company's stock, valued at approximately $1,746,000. BCGM Wealth Management LLC
RIDGELAND, Miss., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (Nasdaq: CALM) (“Cal-Maine Foods,” “we,” “us,” “our” or the “company”), the largest egg company in the United States and a leading player in the egg-based food industry, today announced that members of its management team will participate in the 2026 Stephens Annual Investment Conference in Nashville, Tennessee, on Wednesday, November 18, 2026.
Cal-Maine Foods is upgraded to Strong Buy as valuation reflects excessive pessimism amid cyclical egg price weakness. CALM's strategic shift toward value-added and specialty products, with a targeted 60% capacity increase, aims to insulate overall margins from commodity volatility. The company's robust $767.6 million cash position and active buybacks provide resilience and capitalize on current stock weakness.
Cal-Maine Foods, Inc. is downgraded to Hold due to weaker-than-expected profitability amid a sharp decline in conventional egg prices. CALM's operating leverage and cash outflows highlight vulnerability to egg price cycles, despite a strong balance sheet and diversification into specialty and prepared foods. Specialty and prepared foods segments showed resilience, but conventional eggs posted a deeply negative margin, raising concerns about operational efficiency.
It published a quarterly earnings report that featured a steep net loss.
Cal-Maine Foods, Inc. reported a weak quarter with revenue down 41% YoY and EPS of -$1.26, missing consensus. Despite broad segment weakness, early signs of egg price normalization and supply rationalization suggest potential for a cyclical upturn. CALM maintains a strong balance sheet, continues M&A and CapEx, and trades at EV-to-Sales below 1x, supporting a margin of safety.
Cal-Maine Foods, Inc. (CALM) Q1 2027 Earnings Call Transcript